How New Growth Drivers Are Shaping What Analysts Think Gives BrightSpring Health Services The Edge
BrightSpring Health Services latest update nudges its fair value estimate slightly higher to about $40.54 per share, underpinned by steady revenue growth expectations of roughly 12.49% and a largely unchanged discount rate near 6.96%. The modest bump reflects growing conviction in the companys ability to win additional limited distribution drug contracts and unlock further upside from generic conversions and Provider Services opportunities. Read on to see what is driving this evolving...